Study: GLP-1 drugs do protect muscle during weight loss

Concerns about muscle wasting during rapid weight loss have followed every major breakthrough in weight-loss treatment. With the rise of GLP-1 medicines such as Zepbound (tirzepatide) and Wegovy (semaglutide), that concern has resurfaced, especially as these drugs can produce significant and rapid reductions in body weight. The key question is whether that weight loss comes at […]
Study shows that early use of tirzepatide for diabetes yields cardiac benefits

Early use of tirzepatide appears to improve blood sugar, weight, and several heart-related risk markers in people with recently diagnosed type 2 diabetes. Interim findings from the SURPASS-EARLY trial conducted by Eli Lilly showed that patients treated within four years of diagnosis achieved stronger glycemic control, greater weight loss, and broader metabolic improvements than those receiving […]
Wegovy pill vs Rybelsus: what’s the difference?

“Wegovy pill” is a term that’s gathering a lot of interest on social media platforms. It refers to a new FDA-approved oral semaglutide tablet doctors can prescribe for weight management. This gets attention because most people are aware of the tremendous changes that the introduction of GLP-1 medications such as Ozempic and Wegovy have made in […]
A Smarter Way to Understand Prediabetes

Both prediabetes and diabetes are very common conditions. Studies have shown that about 38 million adults in the US have been diagnosed as diabetics, which is nearly 15% of the US adult population. Prediabetes is far more common. Reliable estimates put the numbers at just below 100 million adults in the US, although the majority […]
Health Trends to Look out for in 2026

Health trends are easiest to spot when the focus stays close to the present rather than far-off predictions. Looking ahead to 2026, several forces are already shaping how care is delivered, how medications are developed, and how people managing long-term and chronic conditions can find relief from the growing impact of excessive medication costs. These […]
Exercise Is Important for Teens With Type 2 Diabetes

Depression in diabetic teenagers is a real pressure point for many families and clinics. Teens who live with type 2 diabetes carry the daily load of blood sugar checks, food decisions, and health worries. When low mood, sadness, or loss of interest are added on top, life can feel very heavy. New work in physical […]
What to do if GLP-1 Medications Reduce Libido

It’s a difficult question to even ask. Can weight-loss wonder drugs like Ozempic and Wegovy also reduce libido? There’s been a wave of fascination, almost a collective obsession, with this new class of GLP-1 drugs, often described as revolutionary. One topic, however, isn’t being discussed nearly enough. It sits quietly beneath the surface, weighed down […]
Is Rybelsus the same as semaglutide?

There has been a tidal wave of interest in the new “wonder drugs” that are based on chemicals called glucagon-like peptide-1 receptor agonists (GLP-1RA), which have revolutionized treatments of a wide range of potentially serious diseases. Many people are now familiar with the common terms associated with these new treatments, such as Ozempic, Mounjaro, semaglutide […]
Exploring treatment options for fatty liver disease in adults over 40

Metabolic dysfunction–associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease (NAFLD), is becoming one of the most common causes of chronic liver illness among adults over 40. It is strongly linked to obesity, type 2 diabetes, high blood pressure, and high cholesterol. When ignored, MASLD can progress to liver scarring, cirrhosis, and […]
Serena Williams Shows Us the Power of Strength in Self-Care

Watching the finals of the US Tennis Open a few weeks ago, my young niece asked, “How big is the prize?” In my ignorance, I guessed, “It’s a lot of money – probably a million dollars!” My older nephew quickly jumped into the conversation with his iPhone in hand – “No, you’re wrong (implying – […]


